Perspective Therapeutics
CATX
31 hedge funds and large institutions have $6.18M invested in Perspective Therapeutics in 2015 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
150% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 4
15% more funds holding
Funds holding: 27 → 31 (+4)
11% more capital invested
Capital invested by funds: $5.57M → $6.18M (+$610K)
0.11% more ownership
Funds ownership: 0.65% → 0.76% (+0.11%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$780K |
| 2 |
Creative Planning
Overland Park,
Kansas
|
+$68.9K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$58.5K |
| 4 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
+$51.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$26.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
-$42K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$21.9K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$20K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$19.9K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$4.93K |
CATX Hedge Fund Activity: Q2 2015 in Review
31 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q2 2015, worth a combined $6.18M — up 11% from $5.57M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CATX positions and 1 closed out — a net gain of 4 holders — while 10 added to existing stakes and 4 trimmed.
The largest buyer was BlackRock Institutional Trust, adding an estimated $780K. The largest seller was Northern Trust, cutting an estimated $42K.
- 31 institutional investors held Perspective Therapeutics (CATX) as of Q2 2015, up from 27 in Q1 2015.
- Funds reported $6.18M of Perspective Therapeutics stock for Q2 2015, up 11% quarter-over-quarter.
- 5 funds opened new Perspective Therapeutics positions in Q2 2015 and 1 closed out, a net change of +4 holders.
- The largest Perspective Therapeutics buyer in Q2 2015 was BlackRock Institutional Trust, an estimated $780K added.
- The largest Perspective Therapeutics seller in Q2 2015 was Northern Trust, an estimated $42K sold.
Based on aggregated 13F filings for Q2 2015.